- Home
- ANSC vs XNCR Comparison
ANSC vs XNCR Comparison
Compare ANSC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANSC
- XNCR
- Stock Information
- Founded
- ANSC 2021
- XNCR 1997
- Country
- ANSC United States
- XNCR United States
- Employees
- ANSC N/A
- XNCR N/A
- Industry
- ANSC
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ANSC
- XNCR Health Care
- Exchange
- ANSC Nasdaq
- XNCR Nasdaq
- Market Cap
- ANSC 466.6M
- XNCR 547.8M
- IPO Year
- ANSC 2023
- XNCR 2013
- Fundamental
- Price
- ANSC $10.94
- XNCR $10.03
- Analyst Decision
- ANSC
- XNCR Buy
- Analyst Count
- ANSC 0
- XNCR 10
- Target Price
- ANSC N/A
- XNCR $20.22
- AVG Volume (30 Days)
- ANSC 11.5K
- XNCR 862.2K
- Earning Date
- ANSC 01-01-0001
- XNCR 11-05-2025
- Dividend Yield
- ANSC N/A
- XNCR N/A
- EPS Growth
- ANSC N/A
- XNCR N/A
- EPS
- ANSC 0.14
- XNCR N/A
- Revenue
- ANSC N/A
- XNCR $146,929,000.00
- Revenue This Year
- ANSC N/A
- XNCR $23.31
- Revenue Next Year
- ANSC N/A
- XNCR N/A
- P/E Ratio
- ANSC $80.37
- XNCR N/A
- Revenue Growth
- ANSC N/A
- XNCR N/A
- 52 Week Low
- ANSC $10.32
- XNCR $6.92
- 52 Week High
- ANSC $10.94
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ANSC 64.39
- XNCR 74.51
- Support Level
- ANSC $10.91
- XNCR $8.49
- Resistance Level
- ANSC $10.94
- XNCR $8.73
- Average True Range (ATR)
- ANSC 0.01
- XNCR 0.46
- MACD
- ANSC 0.00
- XNCR 0.16
- Stochastic Oscillator
- ANSC 100.00
- XNCR 94.02
About ANSC Agriculture & Natural Solutions Acquisition Corporation
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.